Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections

Peter Ball, Thomas M File, Monique Twynholm, Timothy Henkel

Open source

DOI
10.1016/s0924-8579(01)00359-4
Published
2001-07
Container
International Journal of Antimicrobial Agents
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0924-8579-01-00359-4,
  title = {Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections},
  author = {Peter Ball and Thomas M File and Monique Twynholm and Timothy Henkel},
  year = {2001},
  journal = {International Journal of Antimicrobial Agents},
  doi = {10.1016/s0924-8579(01)00359-4},
  url = {https://doi.org/10.1016/s0924-8579(01)00359-4}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections
AU  - Peter Ball
AU  - Thomas M File
AU  - Monique Twynholm
AU  - Timothy Henkel
PY  - 2001
JO  - International Journal of Antimicrobial Agents
DO  - 10.1016/s0924-8579(01)00359-4
UR  - https://doi.org/10.1016/s0924-8579(01)00359-4
ER  - 

APA

Ball, P., File, T. M., Twynholm, M., & Henkel, T. (2001). Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections. International Journal of Antimicrobial Agents. https://doi.org/10.1016/s0924-8579(01)00359-4

Source records